Market Closed -
Other stock markets
|
After market 01:57:08 pm | |||
5.25 EUR | +1.06% | 5.253 | +0.06% |
Apr. 03 | Nanobiotix completes escalation portion of 2020-0123 study | CF |
Apr. 02 | Nanobiotix Completes Dose Escalation Segment of Phase 1 Study Targeting Non-Small Cell Lung Cancer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.93% | 261M | |
-2.06% | 41.35B | |
+42.15% | 40.38B | |
+1.41% | 39.05B | |
-14.19% | 26.67B | |
+1.81% | 24.07B | |
-24.87% | 18.36B | |
-3.72% | 11.68B | |
+20.71% | 11.6B | |
+7.40% | 11.15B |
- Stock Market
- Equities
- NANO Stock
- News Nanobiotix
- Nanobiotix S A : Hires Bart Van Rhijn as CFO